SWX:COPNPharmaceuticals
Cosmo N.V. (SWX:COPN) Valuation Check As Winlevi Launch Advances Across Europe
Cosmo (SWX:COPN) is back in focus after partner Glenmark Specialty S.A. began rolling out Winlevi cream across several European countries, following European Commission approval for treating acne in adults and adolescents.
See our latest analysis for Cosmo.
Despite the Winlevi rollout and Cosmo presenting at the Jefferies Global Healthcare Conference, the CHF70.5 share price is down 21.93% on a 90 day share price return and 33.11% on a year to date share price return. At the same time, the 1...